News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
207,438 Results
Type
Article (15726)
Company Profile (50)
Press Release (191662)
Multimedia
Podcasts (18)
Webinars (2)
Section
Business (55611)
Career Advice (711)
Deals (8667)
Drug Delivery (45)
Drug Development (31537)
Employer Resources (62)
FDA (5335)
Job Trends (5280)
News (99998)
Policy (7945)
Tag
2024 BioCapital Digital (4)
2024 BioForest Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Premier (1)
Academia (1167)
Accelerated approval (1)
Adcomms (8)
Allergies (29)
Alliances (16059)
ALS (42)
Alzheimer's disease (688)
Antibody-drug conjugate (ADC) (86)
Approvals (5356)
Artificial intelligence (118)
Autoimmune disease (11)
Automation (7)
Bankruptcy (59)
Best Places to Work (4616)
BIOSECURE Act (3)
Biosimilars (17)
Biotechnology (34)
Bladder cancer (25)
Brain cancer (13)
Breast cancer (119)
Cancer (1141)
Cardiovascular disease (81)
Career advice (632)
Career pathing (16)
CAR-T (44)
Cell therapy (127)
Cervical cancer (8)
Clinical research (25468)
Collaboration (357)
Compensation (109)
Complete response letters (8)
COVID-19 (911)
CRISPR (22)
C-suite (82)
Cystic fibrosis (62)
Data (971)
Denatured (6)
Depression (18)
Diabetes (99)
Diagnostics (2064)
Digital health (7)
Diversity (2)
Diversity, equity & inclusion (17)
Drug discovery (63)
Drug pricing (37)
Drug shortages (2)
Duchenne muscular dystrophy (34)
Earnings (18172)
Editorial (16)
Employer branding (7)
Employer resources (58)
Events (30105)
Executive appointments (269)
FDA (5793)
Featured Employer (17)
Friedreich's ataxia (4)
Frontotemporal dementia (2)
Funding (324)
Gene editing (42)
Generative AI (13)
Gene therapy (107)
GLP-1 (316)
Government (1313)
Grass and pollen (2)
Guidances (17)
Healthcare (6246)
Huntington's disease (12)
IgA nephropathy (11)
Immunology and inflammation (47)
Indications (15)
Infectious disease (973)
Inflammatory bowel disease (55)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (44)
Interviews (134)
IPO (4245)
IRA (22)
Job creations (829)
Job search strategy (529)
Kidney cancer (4)
Labor market (8)
Layoffs (136)
Leadership (10)
Legal (1121)
Liver cancer (40)
Lung cancer (312)
Lymphoma (76)
Machine learning (4)
Management (23)
Manufacturing (115)
MASH (31)
Medical device (4416)
Medtech (4418)
Mergers & acquisitions (4579)
Metabolic disorders (277)
Multiple sclerosis (24)
NASH (7)
Neurodegenerative disease (48)
Neuropsychiatric disorders (7)
Neuroscience (929)
NextGen: Class of 2025 (2329)
Non-profit (2796)
Northern California (1052)
Now hiring (3)
Obesity (143)
Opinion (136)
Ovarian cancer (35)
Pain (28)
Pancreatic cancer (31)
Parkinson's disease (82)
Partnered (7)
Patents (70)
Patient recruitment (39)
Peanut (17)
People (17954)
Pharmaceutical (12)
Pharmacy benefit managers (3)
Phase I (8736)
Phase II (11727)
Phase III (7818)
Pipeline (524)
Policy (46)
Postmarket research (644)
Preclinical (3496)
Press Release (20)
Prostate cancer (39)
Psychedelics (8)
Radiopharmaceuticals (105)
Rare diseases (178)
Real estate (1428)
Recruiting (23)
Regulatory (6276)
Reports (17)
Research institute (1123)
Resumes & cover letters (84)
Rett syndrome (1)
RNA editing (1)
RSV (16)
Schizophrenia (29)
Series A (60)
Series B (31)
Service/supplier (2)
Sickle cell disease (23)
Southern California (834)
Special edition (7)
Spinal muscular atrophy (159)
Sponsored (16)
Startups (1332)
Stomach cancer (7)
Supply chain (17)
Tariffs (11)
The Weekly (12)
United States (7546)
Vaccines (230)
Venture capitalists (21)
Weight loss (84)
Women's health (7)
Worklife (9)
Date
Today (16)
Last 7 days (248)
Last 30 days (845)
Last 365 days (11599)
2025 (3510)
2024 (12735)
2023 (14627)
2022 (19804)
2021 (20034)
2020 (18416)
2019 (17702)
2018 (13251)
2017 (10598)
2016 (9961)
2015 (11265)
2014 (7569)
2013 (5920)
2012 (6212)
2011 (6663)
2010 (5428)
Location
Africa (276)
Alabama (32)
Alaska (3)
Arizona (40)
Arkansas (7)
Asia (12920)
Australia (2113)
California (2180)
Canada (476)
China (227)
Colorado (58)
Connecticut (94)
Delaware (64)
Europe (28796)
Florida (240)
Georgia (73)
Idaho (11)
Illinois (157)
India (11)
Indiana (75)
Iowa (5)
Japan (79)
Kansas (30)
Kentucky (8)
Louisiana (2)
Maine (11)
Maryland (268)
Massachusetts (1549)
Michigan (67)
Minnesota (88)
Mississippi (1)
Missouri (30)
Montana (12)
Nebraska (12)
Nevada (16)
New Hampshire (16)
New Jersey (594)
New Mexico (17)
New York (661)
North Carolina (329)
North Dakota (5)
Northern California (1052)
Ohio (57)
Oklahoma (5)
Oregon (21)
Pennsylvania (315)
Puerto Rico (1)
Rhode Island (12)
South America (336)
South Carolina (6)
South Dakota (1)
Southern California (834)
Tennessee (19)
Texas (286)
Utah (56)
Virginia (38)
Washington D.C. (17)
Washington State (192)
West Virginia (1)
Wisconsin (14)
207,438 Results for "sma foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA
January 23, 2025
·
7 min read
Press Releases
FDA approves Roche’s Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy (SMA)
February 13, 2025
·
7 min read
Press Releases
FDA Approves Genentech’s Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy (SMA)
February 13, 2025
·
9 min read
Press Releases
New Novartis Phase III data demonstrate meaningful efficacy and safety results of intrathecal onasemnogene abeparvovec in broad patient population with SMA
March 19, 2025
·
10 min read
Layoffs
Biogen Trims Research Workforce, Higher-Dose SMA Drug Accepted for Regulatory Review
In a good-news-bad-news week for Biogen, the company will cut an undisclosed number of employees, just as a higher dose of its Ionis-partnered therapy Spinraza for spinal muscular atrophy will be considered by the FDA and EMA.
January 23, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Scholar Rock Submits Biologics License Application (BLA) to the U.S. FDA for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA)
January 29, 2025
·
9 min read
Neurodegenerative disease
Biohaven Drug Misses in Phase III for SMA, Will Be Tested in Obesity
While taldefgrobep alfa failed to show improved motor function in spinal muscular atrophy, treated patients saw a marked reduction in body fat. Biohaven plans to launch a Phase II trial in obesity by the end of the year.
November 25, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Novartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children and young adults with SMA
December 30, 2024
·
10 min read
Press Releases
Majority of children with spinal muscular atrophy (SMA) treated with Roche’s Evrysdi are able to sit, stand and walk independently, two-year data demonstrate
October 14, 2024
·
8 min read
Press Releases
Majority of Children With Spinal Muscular Atrophy (SMA) Treated With Genentech’s Evrysdi Are Able to Sit, Stand and Walk Independently, Two-Year Data Demonstrate
October 14, 2024
·
10 min read
1 of 20,744
Next
